Caplin Point Laboratories Ltd
₹2297.10
(1.76%)
Sat, 17 Oct 2026, 11:41 am
Health Technology
Pharmaceuticals: Major
24.5KCaplin Point Laboratories Share Price Live Chart
1 Day
(1.76%)
No Result Found
Summary
Market Cap (in Cr)
18395.21
Net Profit (in Cr)
541.09
P/B
3.39
Sector P/E
36.69
P/E
17.84
EV/EBITDA
12.35
Debt/Equity (Industry)
0.33
Interest Cover (Industry)
13.04
ROCE (Industry)
14.50
RONW (Industry)
13.64
ROE
22.86
ROCE
26.03
Debt/Equity
0
EPS (TTM)
87.53
Dividend Yield
0.33
Book Value
443.33
Interest Cover
1110.48
Shareholding
| Shareholders | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 |
|---|---|---|---|---|---|
| Promoters | 70.57 | 70.57 | 70.57 | 70.57 | 70.56 |
| FII | 5.75 | 6.15 | 6.56 | 6.48 | 6.14 |
| DII | 2.49 | 2.14 | 2.05 | 2.10 | 2.22 |
| Public | 21.18 | 21.14 | 20.82 | 20.85 | 21.08 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 3731.30 | 3231.80 | 2974.10 | 2732.30 | 2474.60 | 2232.80 | 1733.30 |
| Fibonacci | 3231.80 | 3040.99 | 2923.11 | 2732.30 | 2541.49 | 2423.61 | 2232.80 |
| Camarilla | 2853.76 | 2807.97 | 2762.19 | 2732.30 | 2670.61 | 2624.83 | 2579.04 |
Pivots Level: Classic
R3
+999
3731.30
R2
+499.50
3231.80
R1
+241.80
2974.10
S1
-257.70
2474.60
S2
-499.50
2232.80
S3
-999
1733.30
Moving Average
Period
Value
10-EMA
2443.05
20-EMA
2537.26
30-EMA
2571.90
50-EMA
2574.19
100-EMA
2471.37
200-EMA
2297.31
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 12 Aug 2026 | dividend | ₹4.00 Dividend /Share | 18 Sept 2026 |
| 12 Aug 2026 | agm | ||
| 14 May 2026 | board-meetings | Accounts, Interim Dividend | |
| 14 May 2026 | dividend | ₹4.00 Dividend /Share | 30 May 2026 |
| 05 Feb 2026 | board-meetings | Quarterly Results | |
| 05 Nov 2025 | board-meetings | Quarterly Results | |
| 12 Aug 2025 | dividend | Final Dividend - Rs. - 3 | 12 Sept 2025 |
| 07 Aug 2025 | agm | ||
| 07 Aug 2025 | dividend | ₹3.00 Dividend /Share | 12 Sept 2025 |
| 15 May 2025 | dividend | ₹3.00 Dividend /Share | 30 May 2025 |
Peer Comparison
Caplin Point Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Dr Reddys Laboratories Ltd
Divis Laboratories Ltd
Torrent Pharmaceuticals Ltd
Cipla Ltd
Caplin Point Laboratories Ltd About
Caplin Point Laboratories is a progressive pharmaceutical company engaged in the manufacturing and marketing of finished formulations, manufacturing of Active Pharmaceutical Ingredients, Research & Development and Clinical Research. Its unique business model mostly caters to emerging markets of Latin America and Africa. Over the years, with focused and consistent approach, Caplin has established a growing presence in the regulated markets such as the USA.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1990
Headquarters
CEO
C C Paarthipan
Employees
Contact
Website
http://www.caplinpoint.net
investor@caplinpoint.net; info@caplinpoint.net
Phone
91-44-24968000/71148000/28156653
Location
Ashvich Towers 3rd Floor, No 3 Developed Plots Ind Estat, Chennai, Tamil Nadu, 600096
Caplin Point Laboratories Ltd Company History
| Year | History |
|---|---|
| 2018 |
|
| 2019 |
|
| 2020 |
|
| 2021 |
|
| 2023 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 396355 | 1899.6 | 26 Aug 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 396355 | 1901.28 | 26 Aug 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 444478 | 1763.58 | 19 Aug 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 444478 | 1761.72 | 19 Aug 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 381306 | 908.19 | 09 Sept 2021 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 381306 | 908.54 | 09 Sept 2021 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 414981 | 957.62 | 27 Jul 2021 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 414981 | 957.37 | 27 Jul 2021 |
| XTX MARKETS LLP | bulk | Sell | 460816 | 910.58 | 26 Jul 2021 |
| XTX MARKETS LLP | bulk | Buy | 464203 | 908.91 | 26 Jul 2021 |
Frequently Asked Questions
1.What is the stock price of Caplin Point Laboratories Ltd?
As of 17/10/2026 at 5:11 PM, Caplin Point Laboratories Ltd shares are trading at ₹2297.10.
2.What is the market cap. of Caplin Point Laboratories Ltd?
As of 17/10/2026, the market capitalization of Caplin Point Laboratories Ltd is ₹17,940.66 crore.
3.When was Caplin Point Laboratories Ltd founded?
Caplin Point Laboratories Ltd was founded in 1990.
4.What are the P/E and P/B ratios of Caplin Point Laboratories Ltd?
As of 17/10/2026, Caplin Point Laboratories Ltd has a P/E ratio of 26.32 and a P/B ratio of 3.39.
5.How can I buy shares of Caplin Point Laboratories Ltd?
You can buy shares of Caplin Point Laboratories Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Caplin Point Laboratories Ltd?
As of June,2026, promoters hold 70.57% in Caplin Point Laboratories Ltd, while FIIs, DIIs and public shareholders hold 5.75%, 2.49% and 21.18%, respectively.
7.Does Caplin Point Laboratories Ltd pay dividends?
Yes, Caplin Point Laboratories Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹4.00 Dividend /Share per share.
8.What is the dividend yield of Caplin Point Laboratories Ltd?
As of 17 October, 2026, the dividend yield of Caplin Point Laboratories Ltd stands at 0.34%.
9.What are the latest financial results of Caplin Point Laboratories Ltd?
For January,2024, Caplin Point Laboratories Ltd reported revenue of ₹1,921.00 crore and a net profit of ₹536.00 crore.
10.What is the Stock symbol of Caplin Point Laboratories Ltd?
CAPLIPOINT is the stock symbol of Caplin Point Laboratories Ltd.
11.Who is the CEO of Caplin Point Laboratories Ltd?
The CEO of Caplin Point Laboratories Ltd is C C Paarthipan.
